Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLARINET long-term safety extension in infants with cyanotic congenital heart disease and persistent systemic-to-pulmonary artery shunt
2008-004999-53Phase 3Completed
- Sponsor
- Sanofi
- Start
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of clopidogrel in Cardiovascular Malformation (CVM), sponsored by Sanofi. Primary endpoint: Safety. Started Oct 2008; status: completed.
02
Drugs
clopidogrel
03
Conditions
Cardiovascular Malformation (CVM)
Beyond the preview
Go deeper on 2008-004999-53.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004999-53.